Comparing Calquence vs Zanubrutinib
| Calquence (acalabrutinib) | Zanubrutinib |
|
|---|
| Calquence (acalabrutinib) | Zanubrutinib |
|
|---|---|---|
|
Prescription only
Prescribed for Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma. Calquence may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Waldenström Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma. Zanubrutinib may also be used for purposes not listed in... View more |
Related suggestions Mantle Cell Lymphoma
Popular comparisons
|
| More about Calquence (acalabrutinib) | More about Zanubrutinib | |
| Ratings & Reviews | ||
|
Calquence has an average rating of 8.8 out of 10 from a total of 34 ratings on Drugs.com. 88% of reviewers reported a positive effect, while 3% reported a negative effect. |
Zanubrutinib has an average rating of 8.8 out of 10 from a total of 61 ratings on Drugs.com. 82% of reviewers reported a positive effect, while 0% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
|
View all Calquence side effects |
View all Zanubrutinib side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
||
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
|
| Brand Names | ||
|
N/A |
Brukinsa | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
6.9 hours |
4 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 509 drugs are known to interact with Calquence:
|
A total of 527 drugs are known to interact with Zanubrutinib:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
|
|
| Disease Interactions | ||
| First Approval Date | ||
|
October 31, 2017 |
November 14, 2019 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Rituxan
Rituxan is used to treat certain leukemias and lymphomas and some non-cancer conditions, such as ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Kesimpta
Kesimpta is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Zanubrutinib
Zanubrutinib is a targeted treatment that may be used to treat adults with chronic lymphocytic ...
Ibrutinib
Ibrutinib (Imbruvica) is a Bruton's tyrosine kinase inhibitor used for certain blood cancers and ...
Venetoclax
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.